EYUEL TEREFE: Open Payments
NPI 1003341652 · YUMA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$482 in 15 payments from 7 companies in 2025. Trend: 2023 $147 · 2024 $285 · 2025 $482
Food & beverage: $443Education: $39
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 2 | $169 |
| Biogen, Inc. | 4 | $97 |
| Teva Pharmaceuticals USA, Inc. | 3 | $62 |
| E.R. Squibb & Sons, L.L.C. | 2 | $48 |
| Axsome Therapeutics, Inc. | 2 | $40 |
| Lundbeck LLC | 1 | $39 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
Products named: INVEGA SUSTENNA, ZURZUVAE, COBENFY, UZEDY, Auvelity, REXULTI, ABILIFY ASIMTUFII, AUSTEDO XR.
Industry payments across AZ — which companies pay providers there.
